Glipizide Drug Profile

What is Glipizide?

Glipizide is an oral antidiabetic medication belonging to the sulfonylurea class of drugs. It is primarily prescribed to help control blood sugar levels in adults with type 2 diabetes mellitus. This medication works by stimulating the pancreas to release more insulin, helping to lower elevated blood glucose levels when used alongside proper diet and exercise.

Uses

• Type 2 diabetes management: Primary indication for controlling blood sugar levels in adults with non-insulin-dependent diabetes mellitus
• Combination therapy: Often used with other antidiabetic medications like metformin when single-drug therapy is insufficient
• Dietary adjunct: Prescribed alongside dietary modifications and exercise programs to achieve optimal glucose control
• Pre-meal glucose control: Immediate-release formulations help manage post-meal blood sugar spikes
• Long-term glucose management: Extended-release formulations provide sustained blood sugar control throughout the day

How it works

Glipizide works by binding to specific receptors on pancreatic beta cells, which stimulates the release of insulin from the pancreas. This mechanism requires functioning pancreatic beta cells to be effective, which is why it only works in type 2 diabetes and not type 1 diabetes. The increased insulin secretion helps cells throughout the body absorb glucose from the bloodstream, thereby lowering blood sugar levels.

Side effects

Common side effects:

• Hypoglycemia (low blood sugar)
• Nausea and stomach upset
• Diarrhea
• Dizziness
• Headache
• Weight gain
• Skin rash
• Constipation

Serious side effects requiring immediate medical attention:

Submit Your Paper

• Severe hypoglycemia with confusion, seizures, or loss of consciousness
• Allergic reactions including difficulty breathing or swelling of face and throat
• Jaundice or signs of liver problems
• Unusual bleeding or bruising
• Severe skin reactions or blistering

Warnings and precautions

• Kidney and liver function: Dose adjustments may be necessary in patients with impaired kidney or liver function, as the medication is processed through these organs
• Pregnancy and breastfeeding: Generally not recommended during pregnancy as insulin is preferred for blood sugar control; consult healthcare provider about safety during breastfeeding
• Elderly patients: Increased risk of hypoglycemia due to age-related changes in kidney function and metabolism
• Alcohol consumption: Can increase the risk of severe hypoglycemia and should be limited or avoided
• Surgery and illness: May need to be temporarily discontinued during periods of stress, illness, or surgical procedures

Interactions

• Beta-blockers: Can mask symptoms of hypoglycemia and affect blood sugar control
• Warfarin: Glipizide may enhance the blood-thinning effects, increasing bleeding risk
• Fluconazole and other azole antifungals: Can increase glipizide levels and risk of hypoglycemia
• Aspirin and NSAIDs: May enhance hypoglycemic effects when used in high doses
• Corticosteroids: Can reduce the effectiveness of glipizide by increasing blood sugar levels
• Diuretics: May reduce the blood sugar-lowering effects of glipizide
• Alcohol: Significantly increases risk of severe and prolonged hypoglycemia
• Cimetidine: May increase glipizide blood levels and enhance hypoglycemic effects

Check interactions with the GMJ Interaction Checker

Dosage

Immediate-release tablets: Initial dose typically starts at 2.5-5 mg taken 30 minutes before breakfast. Maximum daily dose is generally 40 mg, which may be divided into two doses if needed. Extended-release tablets: Usually started at 2.5-5 mg once daily with breakfast, with a maximum dose of 20 mg daily. Dosage adjustments should be made gradually based on blood glucose response and are typically increased by 2.5-5 mg increments every few weeks. All dosage determinations should be made by a qualified healthcare provider based on individual patient factors including kidney function, other medications, and blood sugar control goals.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).